| Patent application number | Description | Published |
| 20090099259 | Method for regulating gene expression - The present invention is directed to a novel method for modulating the expression of one or more genes in a subject by administering an amount of DHA and ARA to the subject. | 04-16-2009 |
| 20090118227 | CAROTENOID-CONTAINING COMPOSITIONS AND METHODS - The present invention is directed to carotenoid compositions and methods for inhibiting the growth of pathogenic bacteria or for preventing or treating bacterial infections in subjects by administration of an effective amount of astaxanthin and beta-carotene. | 05-07-2009 |
| 20090118228 | CAROTENOID-CONTAINING COMPOSITIONS AND METHODS - The present invention is directed to methods for improving optical or skin health in a subject comprising administering to the subject a combination of lutein, zeaxanthin, lycopene, and beta-carotene. | 05-07-2009 |
| 20090118229 | CAROTENOID-CONTAINING COMPOSITIONS AND METHODS - The present invention is directed to carotenoid-containing compositions and methods for improving bone or respiratory health in a subject comprising administering to the subject a combination of lycopene, beta-carotene, and beta-cryptoxanthin. | 05-07-2009 |
| 20090281108 | PRENATAL DIETARY SUPPLEMENT - The present invention relates to a prenatal dietary supplement comprising at least one omega-3 fatty acid, at least one omega-6 fatty acid; folic acid; lutein; and at least one proanthocyanidin. | 11-12-2009 |
| 20100004334 | Nutritional Compositions Containing Punicalagins - The present invention relates generally to a nutritional composition comprising punicalagins. | 01-07-2010 |
| Patent application number | Description | Published |
| 20100104545 | Nutritional Composition To Promote Healthy Development And Growth - A nutritional composition having a lipid or fat; a protein source; a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; and up to about 2.5% by weight of a source of supplemental calcium which, when dissociated, provides a cation having prebiotic functionality. | 04-29-2010 |
| 20100104696 | Nutritional Composition With Improved Digestibility - The present invention is directed an improved nutritional composition, methods of improving digestion, and methods of enhancing the bioavailability of TGF-β. | 04-29-2010 |
| 20100105080 | Methods For Determining The Bioactivity Of TGF-Beta In A Composition - A novel method for determining the bioactivity of TGF-β in a sample of milk, raw protein source, or nutritional composition is provided. The method includes particular reconstitution steps, centrifugation steps, incubation steps, and activation steps. The bioactivity of the TGF-β in the sample may be measured in a HT-2 cell bioassay or a cellomics bioassay. | 04-29-2010 |
| 20100105083 | Methods For Determining The Levels Of TGF-Beta In A Composition - A novel method for determining the levels of TGF-β1 or TGF-β2 in a sample of milk, raw protein source, or nutritional composition is provided. The method involves, in some cases, reconstituting the sample; in some cases, centrifuging the sample; activating the sample using particular ratios of sample:acid:base; diluting the sample using particular ratios of sample:buffer agent; and determining the concentration of TGF-β1 in the sample using an ELISA assay. | 04-29-2010 |
| 20100105615 | Nutritional Composition To Promote Healthy Development And Growth - A nutritional composition for improving the immunological function of a subject, including a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; and about 0.1 to about 1 mg/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide which has a fermentation rate which is demonstrably slower than that of galacto-oligosaccharide. | 04-29-2010 |
| 20100284980 | Nutritional Composition To Promote Healthy Development And Growth - A nutritional formula which includes a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; about 0.1 to about 1 mg/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide which comprises galacto-oligosaccharide; and about 0.015 to about 0.1 (pg/μg) ppm of TGF-β. | 11-11-2010 |